Back to Results
First PageMeta Content
Health / Microbiology / Vaccination / Ebola virus disease / Zoonoses / Modified vaccinia Ankara / DNA vaccination / H5N1 clinical trials / Influenza vaccine / Biology / Medicine / Vaccines


FDA-Briefing Document-VRBPAC
Add to Reading List

Open Document

File Size: 145,81 KB

Share Result on Facebook

City

Geneva / Lambaréné / Washington DC / Baltimore / Ankara / Ames / Hamburg / /

Company

Merck & Co. Inc. / IgG / Johnson & Johnson / NewLink Genetics Corp. / Ebola Zaire Virus / Bavarian Nordic / GlaxoSmithKline Biologicals / Merck / Crucell Holland B.V. / Merck Sharp & Dohme Corp. / /

Continent

Africa / Europe / /

Country

Switzerland / Germany / Gabon / Sudan / Congo / Guinea / United States / Liberia / Sierra Leone / /

Event

FDA Phase / M&A / Product Issues / /

Facility

National Institute of Allergy / Liberian Institute / Sierra Leone College of Medicine / Liberia College of Physicians / Jenner Institute of Oxford University / Whitehouse Station / /

IndustryTerm

vaccine platform technology / follow-on products / manufacturing / /

MedicalCondition

strain / widespread Ebola / EVD epidemic affecting multiple countries / rare and deadly disease / Ebola candidate vaccines Three Ebola / clinical disease / low Ebola / fatigue / severe headache / diarrhea / rVSV-ZEBOV Ebola / rVSV-ZEBOV investigational Ebola / tumor / abdominal pain / necrosis / disease / Additional Ebola / Ebola / human infections / Ebola virus disease / muscle pain / fever / vomiting / infection / Introduction The Ebola / investigational Ebola / rVSV-ZEBOV candidate Ebola / vesicular stomatitis virus / Virus Recombinant Vesicular Stomatitis Virus-Vectored / /

MedicalTreatment

immunization / vaccination / /

NaturalFeature

Tai Forest / Taï Forest / Sierra Leone / Ebola River / /

Organization

National Institute of Health / World Health Organization / Public Health Agency of Canada / US government / Sierra Leone College of Medicine and Allied Health Sciences / Liberian Institute for Biomedical Research / FDA Briefing Document Vaccines and Related Biological Products Advisory Committee / Centers for Disease Control and Prevention / Vaccine Research Center / National Institute of Allergy and Infectious Diseases / Jenner Institute / FDA / WRAIR / Oxford University / Vaccines and Related Biological Products Advisory Committee / Ministry of Health / Liberia College of Physicians and Surgeons / /

Person

ELISA GMT / /

Product

ReiThera / mBN226B / Ebola / chimpanzee Adenovirus Type / NA4 / ChAd3vectored / adenovirus serotype / Ebola vaccine / /

ProgrammingLanguage

DC / /

ProvinceOrState

Iowa / /

Region

West Africa / /

Technology

alpha / antibodies / GPS / USAMRIID protocol / vaccine platform technology / /

SocialTag